Navigation Links
InspireMD Reports Results For Period Ending Sept. 30, 2012
Date:11/2/2012

TEL AVIV, Israel, November 2, 2012 /PRNewswire/ --

InspireMD, Inc. ("InspireMD" or the "Company") (OTC: NSPR) announced financial results for the period ended September 30, 2012, the first quarter of its 2013 fiscal year.

As previously indicated, revenue declined from the same period in 2011 due mainly to stocking and selling disruptions caused by a realignment of the Company's distributors in advance of the presentation of the MASTER trial of its MGuard™ Embolic Protective Stent (EPS) at the 24th Annual Transcathter Therapeutics (TCT) scientific meeting in Miami on October 24.

The positive results, presented at the TCT's Late Breaking Clinical Trials Session by Study Chairman Gregg W. Stone, MD, showed that the novel MGuard EPS provided a statistically and clinically significant acute advantage and, as a result, may hold the potential to lower the incidence of adverse sequela and prolong survival of heart attack victims.

MGuard EPS is CE Mark approved. It is not approved for sale in the U.S. by the Food and Drug Administration (FDA) at this time. The Company plans to initiate a FDA approval study on or before March 31, 2013.

Key financial highlights 1Q ended September 30, 2012 include:

--Revenue for the period ended September 30, 2012 totaled $509,000, compared to $1,986,000 in the same period in 2011, a decrease of $1,477,000, or 74.4 percent, due largely to anticipated disruptions in stocking and sales activities in the periods leading up to the TCT.

--Gross profit for the Sept. 30 2012 period was $279,000, compared to $1,185,000 for the Sept. 30, 2011 period, a decline of 76.5 percent.

--Total operating expenses for the Sept. 30, 2012 period were $3,560,000, compared to $3,335,000 in the Sept. 30, 2011 period. A $274,000 decrease in G&A in the Sept. 30, 2012 period was offset by a $399,000 increase in R&D (mainly to support the MAST
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... the development and commercialization of a once-daily, oral therapy ... announced today that the U.S. Food and Drug Administration, ... IND, application.  Such clearance will permit Galmed to conduct ... the United States for the treatment ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire-iReach/ -- Reproductive Medicine ... New York ), a nationally and internationally-recognized leader ... requiring reproductive assistance, is pleased to announce a new ... Compassionate Care Programs to recognize the sacrifices made by ... The Compassionate Corps Program will allow qualifying veterans and ...
(Date:7/22/2014)... a privately-held medical products and technologies company, today announced ... financial officer of the company, effective July 22, 2014. ... and chief financial officer of Elan Corporation, a ... part of a senior team that helped build significant ... Perrigo, a pharmaceutical manufacturer, in December 2013. ...
Breaking Medicine Technology:Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3ConvaTec Names Nigel Clerkin Chief Financial Officer 2
... May 24, 2011 Framingham-based Boston Heart Lab announced ... Diagnostics. The company launched its new name and logo ... May 19-22 in New York City. (Logo: ... reputation every day as a high-science, high-service company that,s ...
... NEW YORK, May 24, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p0284639/Triple-Analysis-Lymphoma-Melanoma-and-Peptides.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... cancer drug development strategies in both Lymphoma ...
Cached Medicine Technology:Boston Heart Lab Changes Name to Boston Heart Diagnostics 2Boston Heart Lab Changes Name to Boston Heart Diagnostics 3Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 2Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 3Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 4Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides 5
(Date:7/22/2014)... to a new report "Global Actuators Market by Application ... Mining) & Geography (Asia-Pacific, Europe, Latin America, North America, ... Forecast Analysis (2014 -2019)", published by MarketsandMarkets, Global Actuators ... to reach $59.32 Billion by 2019 and Actuators Market ... of 6.00% to reach $8.67 Billion in 2019. , ...
(Date:7/22/2014)... 2014 The donation from the Edusei Foundation ... facility. In a feat of strategic engineering, such assistance tends ... minds of the beneficiaries. It provided a sense of family ... , The Edusei Foundation donated various amounts of; ... and indomie. , The Government of Ghana established the Kumasi ...
(Date:7/22/2014)... Albany, New York (PRWEB) July 22, 2014 ... market report published by Transparency Market Research ... Market [Technologies: Tumor Cell Enrichment (Filtration, Centrifugation ... Cell Detection (Molecular Methods and Optical Methods) ... Cancer and Others] - Global Industry Analysis, ...
(Date:7/22/2014)... California (PRWEB) July 22, 2014 ... Most Wired survey was conducted by Hospitals ... American Hospital Association, AT&T, CareTech Solutions, The ... McKesson. The Most Wired list recognizes hospitals ... implementation, and evaluates hospitals in four focus ...
(Date:7/22/2014)... 2014 Over the years, medical ... sphere of human anatomy. In the pursuit, pathological ... rendered the possibility of deploying certain tests that ... tissues, in order to detect the presence of ... In-vitro Diagnostics (IVD) have earned the title of ...
Breaking Medicine News(10 mins):Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 3Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 4Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4
... that permits precise tuning of a gene,s expression in a ... of the gene,s role in normal and abnormal cellular function. ... negative feedback loop in the synthetic gene circuit, a concept ... by scientists at The University of Texas M. D. Anderson ...
... NEW YORK (March 10, 2009) -- Health information technology ... functioning a full two years after being established, and ... to a study by investigators at Weill Cornell Medical ... way health care is delivered nationally and locally," says ...
... Conn., March 10 Stamford-based Olympus Partners is ... International Corp. from The Hansen Corporate Group. ... change its name to The Ritedose Corporation (TRC).TRC ... the United States. In the BFS process, ...
... CROSSE, Wis., March 10 Gundersen Lutheran is the ... of distinction from the National Quality Measures for Breast ... to provide the highest level of quality breast health ... honors for Gundersen Lutheran Health System, based in La ...
... Show How Pharmaceutical Marketers Can Leverage Social Media-Style ... 10 Spigit, the leader in idea and ... that company co-founder and CTO Padmanabh Dabke will ... Business Intelligence,s 8th Annual Forum on eMarketing ...
... A diverse coalition of clergy and lay members ... today to call on U.S. Senators Tom Harkin and ... to support legislation that would grant the U.S. Food ... Tom Harkin was a cosponsor of the bill in ...
Cached Medicine News:Health News:Synthetic gene circuit allows precise dosing of gene expression 2Health News:Synthetic gene circuit allows precise dosing of gene expression 3Health News:New York State health IT strategy may be model for the nation 2Health News:New York State health IT strategy may be model for the nation 3Health News:Gundersen Lutheran Breast Center Earns Top National Honor 2Health News:Spigit Enterprise Community Expert to Highlight Enterprise 2.0 Apps for Pharma Companies at Annual CBI eMarketing Forum 2Health News:Spigit Enterprise Community Expert to Highlight Enterprise 2.0 Apps for Pharma Companies at Annual CBI eMarketing Forum 3Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 2Health News:Faith Leaders Call on Iowa Members of Congress to Support Legislation to Protect Kids from Tobacco 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: